+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
All Genders
ID06922669

Study of Glucocorticoids to Treat Acute Drug-Induced Liver Injury with High Bilirubin Levels

Led by General Hospital of Shenyang Military Region · Updated on 2025-12-18

232

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

This trial investigates drug-induced liver injury DILI with hyperbilirubinemia, a condition that can cause serious complications like acute liver failure and death. Researchers aim to explore the efficacy and safety of glucocorticoids in treating acute DILI patients with elevated bilirubin levels through a multicenter randomized controlled trial. The study addresses the limited and controversial evidence regarding glucocorticoid use for this condition. A total of 232 patients will be randomly assigned to receive either conventional treatment alone or conventional treatment combined with glucocorticoids. The glucocorticoid treatment involves an initial intravenous dose of methylprednisolone for one week, possibly extended to two, followed by a tapered oral dose over one to three months. Conventional treatments include various liver-supporting drugs, and additional procedures like plasma exchange or liver transplantation may be used if the liver condition worsens. Participants will be closely monitored with evaluations at two and four weeks for liver injury improvement and enzyme levels, along with tracking progressive liver injury, liver failure, transplantation, survival, and adverse events up to three months. The study also explores inflammatory changes and identifies which patients might benefit from glucocorticoid therapy. Total participation spans from enrollment through three months of follow-up.

CONDITIONS

Brief Title

Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia

Research Team

X

Xingshun Qi

Q

Qianqian Li

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here